A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis

Project: Research

Project Details

StatusActive
Effective start/end date3/04/25 → 2/04/27

Keywords

  • Clinical trials
  • INCB 54707-306
  • Povorcitinib